Beone Medicines Ltd. Class A · SSE:688235
Wu Xiaobin sold 1,484 Beone Medicines Ltd. Class A shares (Form 4)
Traded Jun 8, 2026 · Filed Jun 10, 2026
On Jun 8, 2026, Wu Xiaobin (President and COO) sold 1,484 Beone Medicines Ltd. Class A shares at an average US$269.36 for US$400K, leaving 0 shares. Filed Jun 10, 2026 (Form 4).
- Sold
- 1,484 shares
- Price
- US$269.36 average (US$269.33 to US$270.55)
- Value
- US$400K
- Holding after
- 0 shares
- Trading plan
- No
- Role
- President and COO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | American Depositary Shares | Sale | 1,444 | US$269.33 | 40 | Direct |
| Jun 8, 2026 | American Depositary Shares | Sale | 40 | US$270.55 | 0 | Direct |
Source
Related
- Beone Medicines Ltd. Class A
- Wu Xiaobin
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Wu Xiaobin · Aug 27, 2026
- Form 4 · Wu Xiaobin · Jun 25, 2026
- Form 4 · Wu Xiaobin · Jun 18, 2026
- Form 4 · Wu Xiaobin · Jun 15, 2026
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026